Immune Correction Using Interleukin-1β at Moderate and Severe HSV-Infection

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 14, Issue 2

Abstract

Inclusion of interleukin-1β into complex therapy of severe forms of herpes recurrent, allows to remove very effectively immune disturbances and to prevent occurrence of new infection relapses. Prophylactic prescription of interleukin-1β during remission period of herpes recurrent also demonstrated advisability of the therapy. On the background of therapy with interleukin-1β, 12 patients had remission duration. So, in 10 patients prior to therapy with interleukin-1β, remission duration was 1.5 – 2 months, and after the therapy in 9 of them it increased to 10 – 11 months. In 5 female patients, remission duration was 2 – 3 months, after the treatment using interleukin-1β remission lasted more than 12 months. 3 patients during 2-year follow-up had no relapses at all. Anti-recurrent effect of interleukin-1β is related with immunomodulatory properties of the preparation, consisting of increased content of ripe lymphocytes and active lymphocytes (CD25+), as well as increased values of spontaneous and induced LPS NBT-test.

Authors and Affiliations

A. M. Kurmanova, G. М. Kurmanova, L. K. Smailova

Keywords

Related Articles

Performance of First Response® and CareStart™ Malaria Rapid Diagnostic Tests for the Detection of Plasmodium falciparum in a Tertiary Hospital in Ghana

Background: Malaria poses a major public health problem in sub-Saharan Africa. In Ghana, millions of people are potentially at risk of Plasmodium falciparum infections annually. The current study evaluated the performanc...

Studying the Rate of Physical and Emotional Abuse among Elementary School Students of Isfahan in 2014 and Its Relation with Some of the Cognitive Demographic Characteristics for Better Health Care

Aim: Determining the rate of physical and emotional abuse among elementary school students of Isfahan and its relation with demographic characteristics Place and Duration of the Study: The study was conducted in 12 eleme...

Nasopharyngeal Carcinoma: An Awareness and Screening Initiative in Boston’s Chinatown

Aims: Our objective is to describe our institutional experience with nasopharyngeal carcinoma (NPC), and the initiation of a community education and screening program. Study Design: Retrospective case series; academic m...

Ambulatory Phonation Monitor as an Indicator of Voice Use Profile in a Group of Speech Language Pathologists

Aim: Speech-language pathologists (SLPs) can be recognized as professional voice users, as their job depends mainly on healthy and intact voices. The purpose of this study was to explore the vocal load characteristics in...

A Questionnaire Survey of Perceptions of Basic Life Support (BLS) among Radiological Technologists: Radiological Technologists Often Encounter Patients with Cardiopulmonary Arrest during Diagnostic Imaging Examinations

Aim: The present study aims to investigate the perceptions of basic life support (BLS), motivations for learning BLS and self-evaluations of the ability to practice BLS skills in radiological technologists clinically wor...

Download PDF file
  • EP ID EP340041
  • DOI 10.9734/BJMMR/2016/24268
  • Views 75
  • Downloads 0

How To Cite

A. M. Kurmanova, G. М. Kurmanova, L. K. Smailova (2016). Immune Correction Using Interleukin-1β at Moderate and Severe HSV-Infection. Journal of Advances in Medicine and Medical Research, 14(2), 1-8. https://www.europub.co.uk/articles/-A-340041